Immune-mediated animal models of Tourette syndrome

被引:34
|
作者
Hornig, Mady [1 ,2 ]
Lipkin, W. Ian [1 ,2 ,3 ,4 ]
机构
[1] Columbia Univ, Mailman Sch Publ Hlth, Ctr Infect & Immun, New York, NY 10027 USA
[2] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA
[3] Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY USA
[4] Columbia Univ, Coll Phys & Surg, Dept Pathol, New York, NY USA
来源
基金
美国国家卫生研究院;
关键词
Tourette syndrome; Obsessive-compulsive disorder; Autism; Streptococcus; Cytokine; Autoimmunity; Autoantibody; Striatum; Cerebellum; Stereotypic behavior; Mice; OBSESSIVE-COMPULSIVE DISORDER; TUMOR-NECROSIS-FACTOR; BASAL GANGLIA ANTIBODIES; MYCOPLASMA-PNEUMONIAE INFECTION; COMPLEMENT COMPONENTS C-3; INDUCED SICKNESS BEHAVIOR; LYMPHOCYTE ANTIGEN D8/17; BLOOD-BRAIN-BARRIER; T PLUS TF/J; NEUROPSYCHIATRIC DISORDERS;
D O I
10.1016/j.neubiorev.2013.01.007
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
An autoimmune diathesis has been proposed in Tourette syndrome (TS) and related neuropsychiatric disorders such as obsessive-compulsive disorder, attention-deficit/hyperactivity disorder, autism and anorexia nervosa. Environmental triggers including infection and xenobiotics are hypothesized to lead to the production of brain-directed autoantibodies in a subset of genetically susceptible individuals. Although much work has focused on Group A Streptococcus (GAS), the role of this common childhood infection remains controversial. Animal model studies based on immune and autoantibody findings in TS have demonstrated immunoglobulin (Ig) deposits and stereotypic movements and related behavioral disturbances reminiscent of TS following exposure to GAS, other activators of host anti-microbial responses, soluble immune mediators and anti-GAS or anti-neuronal antibodies. Demonstration of the ability to recreate these abnormalities through passive transfer of serum IgG from GAS-immunized mice into naive mice and abrogation of this activity through depletion of IgG has provided compelling evidence in support of the autoimmune hypothesis. Immunologically-based animal models of TS are a potent tool for dissecting the pathogenesis of this serious neuropsychiatric syndrome. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1120 / 1138
页数:19
相关论文
共 50 条
  • [1] Animal models of immune-mediated neuropathies
    Mäurer, M
    Gold, R
    [J]. CURRENT OPINION IN NEUROLOGY, 2002, 15 (05) : 617 - 622
  • [2] Animal models for immune-mediated cholangiopathies
    Ishii, M
    Ueno, Y
    Mano, Y
    Yahagi, K
    Kobayashi, K
    Shimosegawa, T
    Toyota, T
    [J]. PROGRESS IN HEPATOLOGY, VOL 5: LIVER AND IMMUNOLOGY, 1999, 1188 : 117 - 124
  • [3] Animal models of immune-mediated demyelinating polyneuropathies
    Ubogu, Eroboghene E.
    [J]. AUTOIMMUNITY, 2024, 57 (01)
  • [4] Animal models of Tourette syndrome
    Bortolato, Marco
    Di Giovanni, Giuseppe
    [J]. JOURNAL OF NEUROSCIENCE METHODS, 2017, 292 : 1 - 1
  • [5] Pharmacological animal models of Tourette syndrome
    Bronfeld, Maya
    Israelashvili, Michal
    Bar-Gad, Izhar
    [J]. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2013, 37 (06): : 1101 - 1119
  • [6] Experimental animal models of aspergillosis: Contribution to the current knowledge of immune-mediated susceptibility
    Kataranovski, M. V.
    [J]. MYCOSES, 2017, 60 : 38 - 38
  • [7] Immune-mediated components of hereditary demyelinating neuropathies: lessons from animal models and patients
    Martini, R
    Toyka, KV
    [J]. LANCET NEUROLOGY, 2004, 3 (08): : 457 - 465
  • [8] Animal Models for Autoimmune Liver Disease - What Is Relevant for Immune-Mediated Liver Disease
    Hardtke-Wolenski, Matthias
    Taubert, Richard
    Jaeckel, Elmar
    [J]. DIGESTIVE DISEASES, 2012, 30 : 2 - 10
  • [9] Animal Models Recapitulating the Multifactorial Origin of Tourette Syndrome
    Macri, Simone
    Onori, Martina Proietti
    Roessner, Veit
    Laviola, Giovanni
    [J]. ADVANCES IN THE NEUROCHEMISTRY AND NEUROPHARMACOLOGY OF TOURETTE SYNDROME, 2013, 112 : 211 - 237
  • [10] Using animal models to develop therapeutics for Tourette Syndrome
    Swerdlow, NR
    Sutherland, AN
    [J]. PHARMACOLOGY & THERAPEUTICS, 2005, 108 (03) : 281 - 293